Purchase Order 75D30124P18800
- Not listed
- This federal contract award, valued at $12,500.00, was made by the Centers for Disease Control and Prevention (CDC) Pittsburgh to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for a GridION software license and device warranty. Oxford Nanopore Technologies specializes in nanopore-based electronic systems for analyzing single molecules, including DNA, RNA, and proteins, and has secured numerous federal contracts to supply next-generation...
- This is a $95,755 firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, for the acquisition of GridION MK1 CAPEX equipment. The award has no set-aside designation. Oxford Nanopore Technologies Inc. has received multiple prime federal contract awards from agencies such as the NIH, USDA, and DOD to provide next-generation genomic sequencing platforms, consumables,...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $140,950 firm fixed price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit organization, for the GRIDION MK1 CAPEX. The contract, which does not have a set-aside designation, is for the delivery of Oxford Nanopore's nanopore sequencing devices, flow cells, reagents, kits, software, and related services and support. The contract will be performed in Lexington,...
- This is a federal purchase order award to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, for the delivery of ONT MinION sequencing kits. The $21,577 firm-fixed-price contract was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian agency, with a period of performance ending on September 29, 2024. No set-aside was used for this award. Oxford Nanopore Technologies is a prime contractor for this purchase order and...
- The Department of Health and Human Services Centers for Disease Control and Prevention has awarded a firm fixed price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit company, to provide a GridION Mk1 capex sequencing system and associated lab equipment and supplies. The $126,680 contract has a completion date of December 13, 2022 and does not utilize a set-aside designation. Based on previous federal contract awards, Oxford Nanopore Technologies Inc. provides...
- This federal contract award is for the procurement of lab instrument software from Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The $12,500 firm-fixed-price purchase order was issued by the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian agency, with a completion date of August 31, 2024. Oxford Nanopore Technologies is a provider of next-generation genomic sequencing equipment, consumables, and associated services to various...
- This is a $12,500.00 firm fixed price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for the acquisition of a license and warranty for the GridION device to perform whole genome sequencing (WGS) at the CDC/DGHP laboratory on behalf of the CDC in Thailand. The contract has no set-aside designation. Oxford Nanopore...
- Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, was awarded a $9,350 firm fixed-price purchase order (Contract ID 75D30123P15957) by the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian agency, for equipment software licenses and warranties. The contract has an ultimate completion date of April 30, 2023 and does not utilize a set-aside. This award is part of Oxford Nanopore's broader portfolio of federal contracts, which include...
- This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company, is for the provision of sequencing technology and associated services to support research initiatives. The $20,210 firm fixed price purchase order, awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh, does not have a set-aside designation. Oxford Nanopore Technologies holds additional federal contract vehicles, including a $300,000 blanket purchase...
- This is a federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, by the Centers for Disease Control and Prevention (CDC) Pittsburgh, a civilian federal agency. The contract is for the delivery of laboratory equipment, specifically next-generation genomic sequencing devices, consumables, and associated services. The contract has no set-aside designation and is a firm fixed-price purchase order with a ceiling value of $68,067.00. The award...
This is a federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, by the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian agency. The contract, valued at $12,500.00, is for an ONT GridION Service Maintenance Agreement and does not have a set-aside designation. Oxford Nanopore Technologies specializes in developing and manufacturing advanced nanopore-based electronic systems for analyzing single molecules, including DNA, RNA, and proteins. Through this contract, the company will provide the CDC with GridION sequencing platforms, consumables, reagents, software licenses, and associated services. The company holds several federal Indefinite Delivery Vehicles (IDVs) with agencies like the Defense Health Agency, USDA, and HHS, which facilitate the streamlined procurement of its cutting-edge sequencing technologies for various government research programs and initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Terminate for Convenience | $0 | 5/2/25 | |
| Not listed | Not listed | $12.5k | 4/2/24 |